PIM2 and neoplasm: In endometrial cancer, PIM2 has been shown to inhibit AMPKα1 kinase activity through direct phosphorylation on Thr-467, leading to the decrease of AMPKα1 kinase activity and the promotion of aerobic glycolysis and tumor growth 13.